Medicine and Dentistry
Adenocarcinoma
12%
Adjuvant Chemotherapy
6%
Biological Marker
43%
Bladder Cancer
12%
Body Mass Index
10%
Cancer Cell
5%
Chemotherapy
5%
Cohort Analysis
17%
Colon
20%
Colorectal Cancer
100%
Esophageal Adenocarcinoma
24%
Hazard Ratio
15%
Ligand
12%
Lymph Node Metastasis
16%
Man
5%
Neoadjuvant Chemotherapy
12%
Overall Survival
27%
Patient
42%
Primary Tumor
18%
Prognosis
49%
Prognostic Factor
11%
Programmed Death-Ligand 1
12%
Proportional Hazards Model
12%
Protein
73%
Rectum
10%
Regression Analysis
9%
Tissue Microarray
12%
Tumor Infiltrating Lymphocyte
12%
Waist-Hip Ratio
5%
Woman
5%
Biochemistry, Genetics and Molecular Biology
KRAS
13%
PD-L1
24%
Protein
73%
Immunology and Microbiology
Cell Adhesion
8%
Cell Marker
8%
Immune Landscape
5%
Immunocompetent Cell
12%
Prognostic Biomarker
12%
Programmed Death-Ligand 1
24%
Real-Time Polymerase Chain Reaction
5%
Waist Hip Ratio
10%